Insights & Analysis

Expert perspectives on omics, regulatory science, evidence-based medicine, and scientific publishing.

A Practical Guide to PRISMA 2020: What Changed and Why It Matters

The 2020 update to PRISMA introduced significant changes for systematic reviewers. Here is what every researcher needs to know before their next meta-analysis.

Full article content to be added by the editorial team.

May 2026 · 1 min read
Read article →

Five Common IND Application Mistakes That Trigger FDA Clinical Holds

Based on analysis of public FDA Clinical Hold letters, these are the most frequent deficiencies in first-time IND submissions and how to avoid them.

Full article content to be added by the editorial team.

May 2026 · 1 min read
Read article →

Selecting the Right Journal for Your Omics Study: A Decision Framework

Impact factor is only one factor. A systematic approach to journal selection that considers scope, turnaround, open access policies, and reviewer pools.

Full article content to be added by the editorial team.

May 2026 · 1 min read
Read article →